Business Description
Krebs Biochemicals & Industries Ltd
ISIN : INE268B01013
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | -0.7 | |||||
Debt-to-Equity | -1.57 | |||||
Debt-to-EBITDA | -20.97 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -0.18 | |||||
Beneish M-Score | 1.7 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.9 | |||||
3-Year EBITDA Growth Rate | 23.7 | |||||
3-Year EPS without NRI Growth Rate | 14 | |||||
3-Year FCF Growth Rate | 51.5 | |||||
3-Year Book Growth Rate | -36.4 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 93.55 | |||||
9-Day RSI | 87.1 | |||||
14-Day RSI | 81.82 | |||||
6-1 Month Momentum % | 17.83 | |||||
12-1 Month Momentum % | -2.56 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.25 | |||||
Quick Ratio | 0.18 | |||||
Cash Ratio | 0.11 | |||||
Days Inventory | 107.63 | |||||
Days Sales Outstanding | 13.04 | |||||
Days Payable | 199.37 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.2 | |||||
Shareholder Yield % | -7.59 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 36.07 | |||||
Operating Margin % | -32.79 | |||||
Net Margin % | -42.92 | |||||
FCF Margin % | -9.91 | |||||
ROA % | -12.05 | |||||
ROIC % | -7.85 | |||||
ROC (Joel Greenblatt) % | -11.09 | |||||
ROCE % | -15.49 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.32 | |||||
Price-to-Operating-Cash-Flow | 117.31 | |||||
EV-to-EBIT | -27.99 | |||||
EV-to-EBITDA | -47.53 | |||||
EV-to-Revenue | 9.14 | |||||
EV-to-FCF | -73.95 | |||||
Earnings Yield (Greenblatt) % | -3.58 | |||||
FCF Yield % | -1.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Krebs Biochemicals & Industries Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 506.943 | ||
EPS (TTM) (₹) | -10.1 | ||
Beta | 1.72 | ||
Volatility % | 51.79 | ||
14-Day RSI | 81.82 | ||
14-Day ATR (₹) | 6.891206 | ||
20-Day SMA (₹) | 89.1285 | ||
12-1 Month Momentum % | -2.56 | ||
52-Week Range (₹) | 60 - 129 | ||
Shares Outstanding (Mil) | 21.56 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Krebs Biochemicals & Industries Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Krebs Biochemicals & Industries Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Krebs Biochemicals & Industries Ltd Frequently Asked Questions
What is Krebs Biochemicals & Industries Ltd(BOM:524518)'s stock price today?
When is next earnings date of Krebs Biochemicals & Industries Ltd(BOM:524518)?
Does Krebs Biochemicals & Industries Ltd(BOM:524518) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |